Organization Profile

Related Organization(s)

You just read:

EB Pharma Announces License Agreement for Investigational Drug, Tipifarnib from Janssen Pharmaceutica for Development in Hepatitis Delta Virus (HDV) Infection

News provided by

Eiger Bio, Inc.

Dec 23, 2014, 07:00 ET